基于肝脾肾讨论原发性骨质疏松症共病
A Discussion on Primary Osteoporosis Comorbidities Based on Liver, Spleen, and Kidney Functions
DOI: 10.12677/jcpm.2024.34358, PDF,   
作者: 何寅锐, 张通海:南京中医药大学第一临床医学院,江苏 南京;陈世洲, 毛国庆*:南京中医药大学附属医院/江苏省中医院,江苏 南京
关键词: 骨质疏松症中医共病治疗肝脾肾Osteoporosis Traditional Chinese Medicine Comorbidity Liver Spleen and Kidney
摘要: 本文探讨了骨质疏松症及其相关共病的中医防治策略。骨质疏松症是一种表现为骨密度降低、骨脆性增加的全身性疾病,常伴发骨性关节炎、腰椎间盘突出及肌少症。中医认为,该病的发病机制与肝、脾、肾功能的失调密切相关。基于“肝肾同源”和“脏腑辨证”的中医理论,文章提出了以补肾强骨、疏肝柔筋、健脾养血为核心的综合治疗方案,从整体上进行调理,以有效防治骨质疏松症及其共病。文章对中医防治骨质疏松症及其共病的理论基础和临床应用进行了深入分析,为进一步的研究和实践提供了重要参考。
Abstract: This article delves into the Traditional Chinese Medicine (TCM) approaches for the prevention and treatment of osteoporosis and its associated comorbidities. Osteoporosis is a systemic disorder characterized by reduced bone density and increased bone fragility, often accompanied by osteoarthritis, lumbar disc herniation and sarcopenia. In TCM, the pathogenesis of osteoporosis is closely linked to the dysfunctions of the liver, spleen, and kidneys. Drawing on the TCM principles of “liver and kidney from same source” and “syndrome differentiation of Zang-Fu viscera”, the paper proposes a comprehensive treatment strategy centered on fortifying the kidneys and bones, soothing the liver and tendons and nourishing the spleen and blood. This holistic approach is designed to effectively address both osteoporosis and its related comorbidities. The paper offers a thorough analysis of the theoretical underpinnings and clinical applications of TCM in managing osteoporosis, providing significant insights for advancing research and clinical practice.
文章引用:何寅锐, 张通海, 陈世洲, 毛国庆. 基于肝脾肾讨论原发性骨质疏松症共病[J]. 临床个性化医学, 2024, 3(4): 2512-2518. https://doi.org/10.12677/jcpm.2024.34358

参考文献

[1] 中华医学会骨质疏松和骨矿盐疾病分会, 章振林. 原发性骨质疏松症诊疗指南(2022) [J]. 中国全科医学, 2023, 26(14): 1671-1691.
[2] 许慎, 卢春燕, 王覃, 等. 住院骨质疏松症患者共病分析研究[J]. 中国全科医学, 2020, 23(21): 2621-2630.
[3] 林贤灿, 吴建军, 黄宏兴, 等. 我国基层骨质疏松症防治的问题及策略[J]. 中国骨质疏松杂志, 2022, 28(11): 1678-1682.
[4] 郑洪新, 杨柱. 中医基础理论[M]. 北京: 中国中医药出版社, 2021: 12.
[5] 耿春梅, 陈奇刚, 刘杏蓉, 等. 原发骨质疏松症痛点分布与经筋理论相关性的临床研究[J]. 四川中医, 2022, 40(2): 186-190.
[6] 田红莹. 温针灸联合腹部推拿治疗绝经后骨质疏松症临床研究[D]: [硕士学位论文]. 长春: 长春中医药大学, 2022.
[7] 姜劲挺, 郑吉元, 李振豪, 等. 基于“疏肝补肾”法治疗骨质疏松并腰椎间盘突出症的思路探析[J]. 中国中医基础医学杂志, 2017, 23(3): 367-370.
[8] 秦大平, 张晓刚, 宋敏, 张华, 曹林忠, 高国栋, 赵文韬, 王志鹏, 徐斌, 徐世伟. 从筋骨并重理论探讨肌少症与骨质疏松症的中医药防治策略[J]. 中华中医药杂志, 2019, 34(9): 4364-4369.
[9] 陈海霞, 张开伟, 马文娟, 等. 补肾活血汤干预骨质疏松并骨关节炎模型兔软骨多种细胞因子mRNA的表达[J]. 中国组织工程研究, 2018, 22(32): 5123-5132.
[10] 王明远. 补益肝肾方对骨质疏松症大鼠miRNA表达及软骨下骨组织学影响的研究[D]: [博士学位论文]. 北京: 中国中医科学院, 2022.
[11] 赵佳盛, 阮丹丹, 郁啸云, 等. 益气化瘀补肾方联合西药治疗肾虚血瘀型腰椎退行性骨关节炎伴骨质疏松临床观察[J]. 辽宁中医杂志, 2022, 49(12): 116-120.
[12] 崔龙慷, 李学飞, 沈高波, 等. 强骨饮联合西药治疗肾虚血瘀型膝骨关节炎合并骨质疏松症临床疗效观察[J]. 中华中医药杂志, 2022, 37(9): 5512-5516.
[13] Zhu, Z., Hu, G., Jin, F. and Yao, X. (2021) Correlation of Osteoarthritis or Rheumatoid Arthritis with Bone Mineral Density in Adults Aged 20-59 Years. Journal of Orthopaedic Surgery and Research, 16, Article No. 190. [Google Scholar] [CrossRef] [PubMed]
[14] Choi, E., Shin, H.D., Sim, J.A., Na, Y.G., Choi, W., Shin, D., et al. (2021) Relationship of Bone Mineral Density and Knee Osteoarthritis (Kellgren-Lawrence Grade): Fifth Korea National Health and Nutrition Examination Survey. Clinics in Orthopedic Surgery, 13, 60-66. [Google Scholar] [CrossRef] [PubMed]
[15] Ma, C., Aitken, D., Wu, F., Squibb, K., Cicuttini, F. and Jones, G. (2022) Association between Radiographic Hand Osteoarthritis and Bone Microarchitecture in a Population-Based Sample. Arthritis Research & Therapy, 24, Article No. 223. [Google Scholar] [CrossRef] [PubMed]
[16] Gao, Y., Patil, S. and Jia, J. (2021) The Development of Molecular Biology of Osteoporosis. International Journal of Molecular Sciences, 22, Article 8182. [Google Scholar] [CrossRef] [PubMed]
[17] Zhu, S., Zhu, J., Zhen, G., Hu, Y., An, S., Li, Y., et al. (2019) Subchondral Bone Osteoclasts Induce Sensory Innervation and Osteoarthritis Pain. Journal of Clinical Investigation, 129, 1076-1093. [Google Scholar] [CrossRef] [PubMed]
[18] 赵文海, 张俐, 温建民. 中医骨伤科学[M]. 北京: 科学出版社, 2017: 278.
[19] 章圣龑, 夏永法, 王喜波, 等. 杨友发从痰瘀论治腰椎间盘突出症经验介绍[J]. 新中医, 2023, 55(3): 212-215.
[20] 肖志锋. 椎间盘退变与椎体骨质疏松的关系及补肾中药对其小鼠模型的干预作用[D]: [博士学位论文]. 广州: 广州中医药大学, 2018.
[21] 王亚渭, 陈军, 张春涛. 通经补肾益髓汤联合调督理筋针法对腰椎间盘突出症的疗效及对血清PGE2、p-P38MAPK水平的影响[J]. 中华中医药学刊, 2023, 41(5): 52-55.
[22] 韩涛, 孙凯, 孙传睿, 等. 骨质疏松症与腰椎间盘突出症共病调查及影响因素分析[J]. 中国全科医学, 2022, 25(35): 4375-4380.
[23] 梁旺全, 杨卫保, 王辉. 肥胖及骨密度与腰椎间盘退变程度的相关性研究[J]. 颈腰痛杂志, 2021, 42(4): 508-511.
[24] 张勇, 杜世新, 白新明, 等. 绝经期骨质疏松症与腰椎间盘退变的相关性分析[J]. 颈腰痛杂志, 2019, 40(1): 125-127.
[25] Geng, J., Wang, L., Li, Q., Huang, P., Liu, Y., Blake, G.M., et al. (2021) The Association of Lumbar Disc Herniation with Lumbar Volumetric Bone Mineral Density in a Cross-Sectional Chinese Study. Diagnostics, 11, Article 938. [Google Scholar] [CrossRef] [PubMed]
[26] Ding, Y., Chen, J., Yang, J., Li, R., Yin, Y., Chen, J., et al. (2023) Disc Degeneration Contributes to the Denser Bone in the Subendplate but Not in the Vertebral Body in Patients with Lumbar Spinal Stenosis or Disc Herniation. The Spine Journal, 23, 64-71. [Google Scholar] [CrossRef] [PubMed]
[27] 黄研, 邢三丽, 胡怡然, 等. 补肾还精方通过调节铁死亡干预小鼠肌少症的效应和机制研究[J]. 上海中医药杂志, 2022, 56(7): 74-82.
[28] 刘丽萍, 钟玉群, 熊桂梅, 黄绍宽. 健脾补肾膏在老年肌少症中的应用[J]. 内蒙古中医药, 2022, 41(10): 24-26.
[29] Mastavičiūtė, A., Kilaitė, J., Petroška, D., Laurinavičius, A., Tamulaitienė, M. and Alekna, V. (2021) Associations between Physical Function, Bone Density, Muscle Mass and Muscle Morphology in Older Men with Sarcopenia: A Pilot Study. Medicina, 57, Article 156. [Google Scholar] [CrossRef] [PubMed]
[30] Kirk, B., Feehan, J., Lombardi, G. and Duque, G. (2020) Muscle, Bone, and Fat Crosstalk: The Biological Role of Myokines, Osteokines, and Adipokines. Current Osteoporosis Reports, 18, 388-400. [Google Scholar] [CrossRef] [PubMed]
[31] 商海滨, 廉由之, 郭海玲, 杨光月, 邓真, 艾有利, 陈蓓, 李国中, 赵咏芳. 基于生物信息学探讨骨质疏松症与肌少症的关系[J]. 中国骨质疏松杂志, 2021, 27(10): 1458-1463.
[32] 杜丽坤, 李佳睿. 骨质疏松症的中医认识及防治[J]. 中国骨质疏松杂志, 2022, 28(2): 296-299.